Literature DB >> 25392872

[Not Available].

David Krug.   

Abstract

Mesh：

Year:  2014        PMID： 25392872     DOI： 10.1007/s00066-014-0717-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

Review 1.  Local therapy and survival in breast cancer.

Authors:  Rinaa S Punglia; Monica Morrow; Eric P Winer; Jay R Harris
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

2.  The appropriate breast cancer paradigm.

Authors:  S Hellman; J R Harris
Journal:  Cancer Res       Date:  1987-01-15       Impact factor: 12.701

3.  Breast cancer subtypes and the risk of local and regional relapse.

Authors:  K David Voduc; Maggie C U Cheang; Scott Tyldesley; Karen Gelmon; Torsten O Nielsen; Hagen Kennecke
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

4.  Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link.

Authors:  J Van de Steene; G Soete; G Storme
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

Review 5.  Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

Authors:  Patricia Cortazar; Lijun Zhang; Michael Untch; Keyur Mehta; Joseph P Costantino; Norman Wolmark; Hervé Bonnefoi; David Cameron; Luca Gianni; Pinuccia Valagussa; Sandra M Swain; Tatiana Prowell; Sibylle Loibl; D Lawrence Wickerham; Jan Bogaerts; Jose Baselga; Charles Perou; Gideon Blumenthal; Jens Blohmer; Eleftherios P Mamounas; Jonas Bergh; Vladimir Semiglazov; Robert Justice; Holger Eidtmann; Soonmyung Paik; Martine Piccart; Rajeshwari Sridhara; Peter A Fasching; Leen Slaets; Shenghui Tang; Bernd Gerber; Charles E Geyer; Richard Pazdur; Nina Ditsch; Priya Rastogi; Wolfgang Eiermann; Gunter von Minckwitz
Journal:  Lancet       Date:  2014-02-14       Impact factor: 79.321

6.  Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.

Authors:  Marianne Kyndi; Flemming B Sørensen; Helle Knudsen; Marie Overgaard; Hanne Melgaard Nielsen; Jens Overgaard
Journal:  J Clin Oncol       Date:  2008-02-19       Impact factor: 44.544

7.  High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.

Authors:  Marianne Kyndi; Marie Overgaard; Hanne M Nielsen; Flemming B Sørensen; Helle Knudsen; Jens Overgaard
Journal:  Radiother Oncol       Date:  2008-05-28       Impact factor: 6.280

8.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.

Authors:  A Goldhirsch; E P Winer; A S Coates; R D Gelber; M Piccart-Gebhart; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2013-08-04       Impact factor: 32.976
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.